Opeyemi Oladapo-Shittu

Dr. Opeyemi Oladapo-Shittu

Johns Hopkins University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Rasheda KhanamRasheda Khanam
Rasheda Khanam
IKIshaan Kumar
Ishaan Kumar
OOOpeyemi Oladapo-Shittu
Opeyemi Oladapo-Shittu
CTClaire Twose
Claire Twose
ASMD Ashraful IslamASMD Ashraful Islam
ASMD Ashraful Islam
ABAbdullah H. Baqui
Abdullah H. Baqui
Preterm birth (PTB) and its complications are the leading causes of under-five year old child deaths, accounting worldwide for an estimated one million deaths annually. The etiology of PTB is complex and multifactorial. Exposures to environmental metals or metalloids are pervasive and prenatal exposures to them are considered important in the etiology of PTB. We conducted a scoping review to determine the extent of prenatal exposures to four metals/metalloids (lead, mercury, cadmium and arsenic) and their association with PTB. We reviewed original research studies published in PubMed, Embase, the Cochrane Library, Scopus, POPLINE and the WHO regional indexes from 2000 to 2019; 36 articles were retained for full text review. We documented a higher incidence of PTB with lead and cadmium exposures. The findings for mercury and arsenic exposures were inconclusive. Metal-induced oxidative stress in the placenta, epigenetic modification, inflammation, and endocrine disruptions are the most common pathways through which heavy metals and metalloids affect placental functions leading to PTB. Most of the studies were from the high-income countries, reflecting the need for additional data from low-middle-income countries, where PTB rates are higher and prenatal exposure to metals are likely to be just as high, if not higher.

25 March 2022 in American Journal of Infection Control
Verified
Journal Article
Closed access
SHSusan M. Hannum
Susan M. Hannum
OOOpeyemi Oladapo-Shittu
Opeyemi Oladapo-Shittu
ASAlejandra B. Salinas
Alejandra B. Salinas
KWKimberly Weems
Kimberly Weems
JMJill Marsteller
Jill Marsteller
SKSara C. Keller
Sara C. Keller

20 April 2023 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
SKSara C. Keller
Sara C. Keller
SHSusan M. Hannum
Susan M. Hannum
KWKimberly Weems
Kimberly Weems
OOOpeyemi Oladapo-Shittu
Opeyemi Oladapo-Shittu
ASAlejandra B. Salinas
Alejandra B. Salinas
TCthe Home Infusion CLABSI Prevention Collaborative
the Home Infusion CLABSI Prevention Collaborative
Objective: Central-line–associated bloodstream infection (CLABSI) surveillance in home infusion therapy is necessary to track efforts to reduce infections, but a standardized, validated, and feasible definition is lacking. We tested the validity of a home-infusion CLABSI surveillance definition and the feasibility and acceptability of its implementation.Design: Mixed-methods study including validation of CLABSI cases and semistructured interviews with staff applying these approaches.Setting: This study was conducted in 5 large home-infusion agencies in a CLABSI prevention collaborative across 14 states and the District of Columbia.Participants: Staff performing home-infusion CLABSI surveillance.Methods: From May 2021 to May 2022, agencies implemented a home-infusion CLABSI surveillance definition, using 3 approaches to secondary bloodstream infections (BSIs): National Healthcare Safety Program (NHSN) criteria, modified NHSN criteria (only applying the 4 most common NHSN-defined secondary BSIs), and all home-infusion–onset bacteremia (HiOB). Data on all positive blood cultures were sent to an infection preventionist for validation. Surveillance staff underwent semistructured interviews focused on their perceptions of the definition 1 and 3–4 months after implementation.Results: Interrater reliability scores overall ranged from κ = 0.65 for the modified NHSN criteria to κ = 0.68 for the NHSN criteria to κ = 0.72 for the HiOB criteria. For the NHSN criteria, the agency-determined rate was 0.21 per 1,000 central-line (CL) days, and the validator-determined rate was 0.20 per 1,000 CL days. Overall, implementing a standardized definition was thought to be a positive change that would be generalizable and feasible though time-consuming and labor intensive.Conclusions: The home-infusion CLABSI surveillance definition was valid and feasible to implement.

12 January 2023 in American Journal of Infection Control
Verified
Journal Article
Closed access
OOOpeyemi Oladapo-Shittu
Opeyemi Oladapo-Shittu
SHSusan M. Hannum
Susan M. Hannum
ASAlejandra B. Salinas
Alejandra B. Salinas
KWKimberly Weems
Kimberly Weems
JMJill Marsteller
Jill Marsteller
SKSara C. Keller
Sara C. Keller

14 March 2024 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
OOOpeyemi Oladapo-Shittu
Opeyemi Oladapo-Shittu
SCSara E Cosgrove
Sara E Cosgrove
CRClare Rock
Clare Rock
YHYea-Jen Hsu
Yea-Jen Hsu
EKEili Klein
Eili Klein
SKSara C Keller
Sara C Keller
Background: There are no systematic measures of central line–associated bloodstream infections (CLABSIs) in patients maintaining central venous catheters (CVCs) outside acute care hospitals. To clarify the burden of CLABSIs in these patients, we characterized patients with CLABSI present on hospital admission (POA). Methods: Retrospective cross-sectional analysis of patients with CLABSI-POA in 3 health systems covering 11 hospitals across Maryland, Washington DC, and Missouri from November 2020 to October 2021. CLABSI-POA was defined using an adaptation of the acute care CLABSI definition. Patient demographics, clinical characteristics, and outcomes were collected via record review. Cox proportional hazard analysis was used to assess factors associated with the all-cause mortality rate within 30 days. Results: A total of 461 patients were identified as having CLABSI-POA. CVCs were most commonly maintained in home infusion therapy (32.8%) or oncology clinics (31.2%). Enterobacterales were the most common etiologic agent (29.2%). Recurrent CLABSIs occurred in a quarter of patients (25%). Eleven percent of patients died during the hospital admission. Among patients with CLABSI-POA, mortality risk increased with age (hazard ratio vs age <20 years by age group: 20–44 years, 11.2 [95% confidence interval, 1.46–86.22]; 45–64 years, 20.88 [2.84–153.58]; ≥65 years, 22.50 [2.98–169.93]) and lack of insurance (2.46 [1.08–5.59]), and it decreased with CVC removal (0.57 [.39–.84]). Conclusions: CLABSI-POA is associated with significant in-hospital mortality risk. Surveillance is required to understand the burden of CLABSI in the community to identify targets for CLABSI prevention initiatives outside acute care settings.

11 April 2023 in Antimicrobial Stewardship & Healthcare Epidemiology
Verified
Journal Article
Open access
PDF file
SHSusan M. Hannum
Susan M. Hannum
OOOpeyemi Oladapo-Shittu
Opeyemi Oladapo-Shittu
ASAlejandra B. Salinas
Alejandra B. Salinas
KWKimberly Weems
Kimberly Weems
JMJill Marsteller
Jill Marsteller
SKSara C. Keller
Sara C. Keller
Objectives: Access to patient information may affect how home-infusion surveillance staff identify central-line–associated bloodstream infections (CLABSIs). We characterized information hazards in home-infusion CLABSI surveillance and identified possible strategies to mitigate information hazards. Design: Qualitative study using semistructured interviews. Setting and participants: The study included 21 clinical staff members involved in CLABSI surveillance at 5 large home-infusion agencies covering 13 states and the District of Columbia. Methods: Interviews were conducted by 1 researcher. Transcripts were coded by 2 researchers; consensus was reached by discussion. Results: Data revealed the following barriers: information overload, information underload, information scatter, information conflict, and erroneous information. Respondents identified 5 strategies to mitigate information chaos: (1) engage information technology in developing reports; (2) develop streamlined processes for acquiring and sharing data among staff; (3) enable staff access to hospital electronic health records; (4) use a single, validated, home-infusion CLABSI surveillance definition; and (5) develop relationships between home-infusion surveillance staff and inpatient healthcare workers. Conclusions: Information chaos occurs in home-infusion CLABSI surveillance and may affect the development of accurate CLABSI rates in home-infusion therapy. Implementing strategies to minimize information chaos will enhance intra- and interteam collaborations in addition to improving patient-related outcomes.